Related Experiment Video
Updated: Sep 29, 2025

Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Medication and Fluid Management of Pediatric Sepsis and Septic Shock
Lauren Burgunder1, Caroline Heyrend2, Jared Olson2,3
1Division of Pediatric Critical Care, Department of Pediatrics, Primary Children's Hospital, University of Utah, 100 North Mario Capecchi Drive, Salt Lake City, UT, 84113, USA.
Insights
Early recognition and rapid intervention are crucial for treating pediatric sepsis and septic shock. This review covers best practices for fluid resuscitation, antibiotics, and vasoactive medications, addressing ongoing controversies in treatment.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Pharmacology
Background:
- Sepsis is a major global cause of death in neonates and children.
- Effective management requires early recognition, fluid resuscitation, and antibiotics.
- Current guidelines address initial management but controversies persist regarding optimal strategies.
Purpose of the Study:
- To review current recommendations for medication and fluid management in pediatric sepsis and septic shock.
- To highlight key issues in antibiotic selection, fluid resuscitation, and vasoactive/inotropic agent use.
- To discuss controversies and ongoing research in adjunctive therapies.
Main Methods:
- Review of international guidelines for pediatric sepsis and septic shock management.
- Analysis of primary literature on fluid and medication interventions.
- Discussion of current clinical trials and therapeutic nuances.
Main Results:
- Best practice recommendations for fluid resuscitation, antibiotics, and vasoactive/inotropic agents are presented.
- Key areas of controversy include fluid volume/type, antibiotic spectrum, and adjunctive therapies (e.g., vitamin C, steroids).
- Emphasis on antimicrobial stewardship and tailoring antibiotic choices to local epidemiology.
Conclusions:
- Optimal management of pediatric sepsis and septic shock involves a multifaceted approach.
- Further research is needed to resolve controversies regarding fluid resuscitation and adjunctive therapies.
- Adherence to evidence-based guidelines and antimicrobial stewardship is essential for improving outcomes.
Abstract:
Sepsis is a life-threatening response to infection that contributes significantly to neonatal and pediatric morbidity and mortality worldwide. The key tenets of care include early recognition of potential sepsis, rapid intervention with appropriate fluids to restore adequate tissue perfusion, and empiric antibiotics to cover likely pathogens. Vasoactive/inotropic agents are recommended if tissue perfusion and hemodynamics are inadequate following initial fluid resuscitation. Several adjunctive therapies have been suggested with theoretical benefit, though definitive recommendations are not yet supported by research reports. This review focuses on the recommendations for medication and fluid management of pediatric sepsis and septic shock, highlighting issues related to antibiotic choices and antimicrobial stewardship, selection of intravenous fluids for resuscitation, and selection and use of vasoactive/inotropic medications. Controversy remains regarding resuscitation fluid volume and type, antibiotic choices depending upon infectious risks in the patient's community, and adjunctive therapies such as vitamin C, corticosteroids, intravenous immunoglobulin, and methylene blue. We include best practice recommendations based on international guidelines, a review of primary literature, and a discussion of ongoing clinical trials and the nuances of therapeutic choices.
Related Concept Videos
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management

